drugset / Trial / NCT00004730

Magnesium Sulfate For Brain Injury

NCT00004730

Phase 3 Completed University of Washington
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine whether magnesium sulfate, given within 8 hours of a moderate or severe traumatic brain injury improves survival, decreases the number of people developing seizures, improves the survivors' mental and psychological functioning, including the ability to return to daily life, live independently, and return to work or school.

Timeline

Start
1998-08
Primary completion
2005-05
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 0.24 unknown Intravenous